StemMedical’s ambition is the offer stem cell-based treatments at scale that dramatically improve patient quality of life and is, today, working with patients, leading healthcare professionals, and academia to achieve success.
StemMedical is governed by a two-tier management system consisting of a board of directors, responsible for strategic direction and governance, and a management team, responsible for day-to-day management/leadership and strategy execution. In addition, a group of lead advisors cooperate with the company on clinical, scientific, and strategic topics.
The organization is set up in a classic three-pronged split with R&D, operations, and commercial functions, supported by quality/regulatory and administration led by the CFO.
StemMedical’s strong scientific profile is reflected in the skill and experience base among the Management team that includes 4 medical doctors and six Ph.Ds.
Ensuring sustainability while scaling the business is key to our journey. StemMedical supports the United Nations (UN) Sustainable Development Goals (SDGs) and will drive sustainability through a focus on three SDGs: (3) Good Health and Well-being, (9) Innovation and Infrastructure, (12) Responsible Consumption and Production.
The StemMedical Board of Directors implements policies to ensure the ethical conduct and compensation of both its own Board Members as well as the StemMedical Executive Leadership Team.